Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research
Suzannah J. Rihn, Andres Merits, Siddharth Bakshi, et al.
PLoS Biology (2021) Vol. 19, Iss. 2, pp. e3001091-e3001091
Open Access | Times Cited: 209

Showing 1-25 of 209 citing articles:

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
Petra Mlčochová, Steven A. Kemp, Mahesh Shanker Dhar, et al.
Nature (2021) Vol. 599, Iss. 7883, pp. 114-119
Open Access | Times Cited: 1279
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
Brian J. Willett, Joe Grove, Oscar A. MacLean, et al.
Nature Microbiology (2022) Vol. 7, Iss. 8, pp. 1161-1179
Open Access | Times Cited: 531
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
Bo Meng, Steven A. Kemp, Guido Papa, et al.
Cell Reports (2021) Vol. 35, Iss. 13, pp. 109292-109292
Open Access | Times Cited: 412
Rapid assessment of SARS-CoV-2–evolved variants using virus-like particles
Abdullah M. Syed, Taha Y. Taha, Takako Tabata, et al.
Science (2021) Vol. 374, Iss. 6575, pp. 1626-1632
Open Access | Times Cited: 290
The altered entry pathway and antigenic distance of the SARS-CoV-2 Omicron variant map to separate domains of spike protein
Thomas P. Peacock, Jonathan C. Brown, Jie Zhou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 253
A prenylated dsRNA sensor protects against severe COVID-19
Arthur Wickenhagen, Elena Sugrue, Spyros Lytras, et al.
Science (2021) Vol. 374, Iss. 6567
Open Access | Times Cited: 187
Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection
Alexander C. Dowell, Megan Butler, Elizabeth Jinks, et al.
Nature Immunology (2021) Vol. 23, Iss. 1, pp. 40-49
Open Access | Times Cited: 179
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study
Annika Fendler, Scott T.C. Shepherd, Lewis Au, et al.
Nature Cancer (2021) Vol. 2, Iss. 12, pp. 1305-1320
Open Access | Times Cited: 158
In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2
Agnieszka M. Szemiel, Andres Merits, Richard Orton, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 9, pp. e1009929-e1009929
Open Access | Times Cited: 138
The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism
Brian J. Willett, Joe Grove, Oscar A. MacLean, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 135
A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses
Alberto A. Amarilla, Julian D. J. Sng, Rhys Parry, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 130
The mechanism of RNA capping by SARS-CoV-2
Gina J. Park, Adam Osinski, Genaro Hernandez, et al.
Nature (2022)
Open Access | Times Cited: 89
First cases of SARS-CoV-2 BA.2.86 in Denmark, 2023
Morten Rasmussen, Frederik Trier Møller, Vithiagaran Gunalan, et al.
Eurosurveillance (2023) Vol. 28, Iss. 36
Open Access | Times Cited: 51
BTN3A3 evasion promotes the zoonotic potential of influenza A viruses
Rute Maria Pinto, Siddharth Bakshi, Spyros Lytras, et al.
Nature (2023) Vol. 619, Iss. 7969, pp. 338-347
Open Access | Times Cited: 46
Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA.1 variant through NSP6
Taha Y. Taha, Irene P. Chen, Jennifer M. Hayashi, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 44
Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants
Ann‐Kathrin Reuschl, Lucy Thorne, Matthew Whelan, et al.
Nature Microbiology (2024) Vol. 9, Iss. 2, pp. 451-463
Open Access | Times Cited: 41
A cryptic plasmid is among the most numerous genetic elements in the human gut
Emily C. Fogarty, Matthew S. Schechter, Karen Lolans, et al.
Cell (2024) Vol. 187, Iss. 5, pp. 1206-1222.e16
Open Access | Times Cited: 25
Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic
Wilhelm Furnon, Vanessa M. Cowton, Giuditta De Lorenzo, et al.
Nature Microbiology (2025)
Open Access | Times Cited: 1
Emergence of SARS-CoV-2 subgenomic RNAs that enhance viral fitness and immune evasion
Harriet V Mears, George R. Young, Theo Sanderson, et al.
PLoS Biology (2025) Vol. 23, Iss. 1, pp. e3002982-e3002982
Open Access | Times Cited: 1
The SARS-CoV-2 variants associated with infections in India, B.1.617, show enhanced spike cleavage by furin
Thomas P. Peacock, Carol Sheppard, Jonathan C. Brown, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 98
SARS-CoV-2 B.1.617.2 Delta variant replication, sensitivity to neutralising antibodies and vaccine breakthrough
Petra Mlčochová, Steven A. Kemp, Mahesh Shanker Dhar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 96
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study
Annika Fendler, Lewis Au, Scott T.C. Shepherd, et al.
Nature Cancer (2021) Vol. 2, Iss. 12, pp. 1321-1337
Open Access | Times Cited: 82
The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease
Elisa Avolio, Michele Carrabba, Rachel Milligan, et al.
Clinical Science (2021) Vol. 135, Iss. 24, pp. 2667-2689
Open Access | Times Cited: 82
Sarbecovirus ORF6 proteins hamper induction of interferon signaling
Izumi Kimura, Yoriyuki Konno, Keiya Uriu, et al.
Cell Reports (2021) Vol. 34, Iss. 13, pp. 108916-108916
Open Access | Times Cited: 80
Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19
Meehyun Ko, So Young Chang, Soo Young Byun, et al.
Viruses (2021) Vol. 13, Iss. 4, pp. 651-651
Open Access | Times Cited: 77
Page 1 - Next Page

Scroll to top